Resource title

Is quantitative benefit–risk modelling of drugs desirable or possible?

Resource image

image for OpenScout resource :: Is quantitative benefit–risk modelling of drugs desirable or possible?

Resource description

Preliminary research results with drug regulators in several European Agencies show that quantitative models developed with groups of assessors and specialists can integrate scientific data with expert value judgements, thereby extending the capabilities of regulators, and stimulating new insights about key trade-offs. As a result, the rationale for the benefit-risk balance becomes more transparent, communicable and consistent.

Resource author

Resource publisher

Resource publish date

Resource language

en

Resource content type

Resource resource URL

http://eprints.lse.ac.uk/39733/

Resource license